Drug Registration and Acceptance

Drug Name

Exact

Active Ingredient

Acceptance No.

Manufacturers

Acceptance Date

Status Date

Classification

Review Status

Drug Type

Submission

Evaluation Conclusion

ATC Category

Special Approval Varieties

Task Type

Major Special Varieties

Sequence No.

Stock Code

Visualized Analysis Export Evaluation Conclusion Evaluation Progress

Acceptance No.	Drug Name	Active Ingredient	Dosage Form	Classification	Submission	Acceptance Date	Manufacturers	View
CYSB2400295	注射用重组人凝血因子Ⅷ	Recombinant Coagulation Factor Ⅷ	Lyophilized	Biological Products(原10)	Supplementary Application	2024-11-12	SinoCelltech Ltd	view
CYSB2400294	注射用重组人凝血因子Ⅷ	Recombinant Coagulation Factor Ⅷ	Lyophilized	Biological Products(原10)	Supplementary Application	2024-11-12	SinoCelltech Ltd	view
JTS2400104	注射用培重组人凝血因子VIII		Lyophilized	Biological Products	Disposable Import Drug Application	2024-09-25		view
JTS2400108	注射用培重组人凝血因子VIII		Lyophilized	Biological Products	Disposable Import Drug Application	2024-09-25		view
JTS2400109	注射用培重组人凝血因子VIII		Lyophilized	Biological Products	Disposable Import Drug Application	2024-09-25		view
JTS2400110	注射用培重组人凝血因子VIII		Lyophilized	Biological Products	Disposable Import Drug Application	2024-09-25		view
JTS2400107	注射用培重组人凝血因子VIII		Lyophilized	Biological Products	Disposable Import Drug Application	2024-09-25		view
JTS2400105	注射用培重组人凝血因子VIII		Lyophilized	Biological Products	Disposable Import Drug Application	2024-09-25		view
JTS2400106	注射用培重组人凝血因子VIII		Lyophilized	Biological Products	Disposable Import Drug Application	2024-09-25		view
JYSB2400182	注射用重组人凝血因子VIII	Recombinant Coagulation Factor Ⅷ	Lyophilized	Biological Products	Supplementary Application	2024-08-14		view
JYSB2400181	注射用重组人凝血因子VIII	Recombinant Coagulation Factor Ⅷ	Lyophilized	Biological Products	Supplementary Application	2024-08-14		view
JYSB2400179	注射用重组人凝血因子VIII	Recombinant Coagulation Factor Ⅷ	Lyophilized	Biological Products	Supplementary Application	2024-08-14		view
JYSB2400180	注射用重组人凝血因子VIII	Recombinant Coagulation Factor Ⅷ	Lyophilized	Biological Products	Supplementary Application	2024-08-14		view
CXSS2400077	人凝血因子Ⅷ	Recombinant Coagulation Factor Ⅷ	Lyophilized	Biological Products(3.4)	New Drug Application	2024-07-23	Bohui Biopharmaceutical (Hebei) Co Ltd	view
JYSB2400155	注射用重组人凝血因子Ⅷ	Recombinant Coagulation Factor Ⅷ	Lyophilized	Biological Products	Supplementary Application	2024-07-16		view
JYSB2400156	注射用重组人凝血因子Ⅷ	Recombinant Coagulation Factor Ⅷ	Lyophilized	Biological Products	Supplementary Application	2024-07-16		view
JYSB2400157	注射用重组人凝血因子Ⅷ	Recombinant Coagulation Factor Ⅷ	Lyophilized	Biological Products	Supplementary Application	2024-07-16		view
JYSB2400158	注射用重组人凝血因子Ⅷ	Recombinant Coagulation Factor Ⅷ	Lyophilized	Biological Products	Supplementary Application	2024-07-16		view
CYSB2400160	人凝血因子Ⅷ	Recombinant Coagulation Factor Ⅷ	Lyophilized	Biological Products	Supplementary Application	2024-06-21	Chengdu Rongsheng Pharmaceuticals Co Ltd	view
CYSB2400133	注射用重组人凝血因子Ⅷ	Recombinant Coagulation Factor Ⅷ	Lyophilized	Biological Products(原10)	Supplementary Application	2024-05-24	SinoCelltech Ltd	view